Notman Donald
Chief Operating Officer
Notman Donald has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Notman Donald is listed as Chief Operating Officer at OCULAR THERAPEUTIX, INC. Inside the rolling window, Notman Donald reported no open-market purchases and 5 open-market sales totaling $229K in OCUL. The largest disclosed transaction in the window is a sale of 11,446 OCUL shares on Feb 12, 2026, worth $103K.
Companies traded
Other insiders at OCUL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$229K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Notman Donald made?
Notman Donald has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Notman Donald trade?
Notman Donald has filed SEC Form 4 disclosures for 1 company, including OCUL.
When was Notman Donald's most recent SEC Form 4 filing?
Notman Donald's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Notman Donald's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Notman Donald is listed as Chief Operating Officer.
What is Notman Donald's total buy and sell value in the current window?
Inside the rolling retention window, Notman Donald bought $0 and sold $229K based on SEC Form 4 filings.
What was Notman Donald's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,446 OCUL shares on 2026-02-12, worth $103K, per SEC Form 4 filings.